Request for Quotation for the Supply of In Vitro Medical Diagnostic Reagent Kits: Rapid Melioidosis Antibody and Antigen Lateral Flow Assays for NIAID/NIH, U.S. Embassy Phnom Penh

The U.S. Embassy in Phnom Penh is seeking qualified vendors to supply In Vitro Medical Diagnostic Reagent Kits specifically designed for rapid detection of Melioidosis through antibody and antigen lateral flow assays, intended for use by NIAID/NIH in Cambodia. The procurement is issued under solicitation number 19CB6026Q0024, with submissions due by July 30, 2026, at 9:00 AM local time, and the request was posted on July 15, 2026. The contract falls under NAICS code 62151, indicating it is related to medical and diagnostic laboratories, and no set-aside provisions are specified for small businesses or other categories. The equipment is critical for public health efforts in a region where Melioidosis is endemic, requiring reliable, field-deployable diagnostic tools with proven accuracy and stability under tropical conditions. All kits must meet stringent U.S. federal standards for in vitro diagnostics and be suitable for use in resource-limited settings without compromising quality or safety. The point of contact for this solicitation is Kara Finneren, with Phon Chansophal as the secondary liaison, both reachable via email through state.gov addresses. The contracting office is located in Washington, D.C., though the performance location is explicitly Phnom Penh, Cambodia, meaning vendors must ensure timely logistics and supply chain capabilities to deliver to a foreign, potentially remote site. Proposals must align with the detailed requirements in the attached Request for Quotation, including technical specifications, packaging, storage conditions, shelf life, and compliance with international medical device regulations. Vendors should be prepared to provide documentation of product certifications, quality control protocols, and prior experience in supplying similar diagnostic kits to government or international health entities. Delivery timelines, validation data, and post-delivery support may be key factors in evaluation.